Compare IPHA & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPHA | SPCE |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 331.6M |
| IPO Year | 2014 | 2017 |
| Metric | IPHA | SPCE |
|---|---|---|
| Price | $1.92 | $2.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $5.75 | $3.06 |
| AVG Volume (30 Days) | 52.7K | ★ 6.6M |
| Earning Date | 03-26-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,544,000.00 |
| Revenue This Year | $180.36 | $2,270.73 |
| Revenue Next Year | N/A | $880.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.18 | $2.13 |
| 52 Week High | $2.71 | $8.90 |
| Indicator | IPHA | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 41.28 | 47.24 |
| Support Level | $1.67 | $2.84 |
| Resistance Level | $1.95 | $3.39 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 0.00 | 20.90 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.